Related Experiment Video
Updated: Aug 19, 2026
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin
D A Chakkalakal1, T J Mollner, M R Bogard
1Creighton University Biomedical Engineering Center, Creighton University School of Medicine, Omaha, NE 68105, USA.
Abstract:
Morbidity resulting from the toxicity of chemotherapeutic drugs suggests that novel approaches are worthy of investigation. Development of the use of low intensity magnetic fields as an adjuvant to current treatment regimens to prevent metastatic disease may prove to be efficacious. Using a cell culture model, we have developed a magnetic field (MF) treatment that offers the possibility of lowering the therapeutic dose of these drugs and thereby reducing morbidity. Our studies have found that a low intensity (approximately 2 gauss) MF signal and a relatively low dose (0.1 microg/ml) of Adriamycin (ADR) inhibited proliferation of human osteosarcoma cells by 82%, whereas the MF and ADR acting individually caused only 19% and 44% inhibition, respectively.
Insights
Investigating novel cancer therapies, this study shows low-intensity magnetic fields combined with Adriamycin significantly inhibit osteosarcoma cell growth. This combined approach may reduce chemotherapy side effects by lowering drug dosage.
Area of Science:
- Oncology
- Biophysics
Background:
- Chemotherapy drugs like Adriamycin (ADR) can cause significant toxicity and morbidity.
- Preventing metastatic disease is a critical challenge in cancer treatment.
- Novel therapeutic strategies are needed to enhance treatment efficacy and reduce side effects.
Purpose of the Study:
- To investigate the potential of low-intensity magnetic fields (MF) as an adjuvant therapy to reduce Adriamycin dosage and morbidity.
- To evaluate the combined effect of MF and ADR on human osteosarcoma cell proliferation.
Main Methods:
- Utilized a cell culture model of human osteosarcoma.
- Applied a low-intensity magnetic field (approximately 2 gauss).
- Administered Adriamycin (ADR) at a low dose (0.1 microg/ml) both individually and in combination with MF.
Main Results:
- The combination of MF and ADR inhibited human osteosarcoma cell proliferation by 82%.
- MF alone inhibited proliferation by 19%.
- ADR alone inhibited proliferation by 44%.
Conclusions:
- Low-intensity magnetic fields can act as an effective adjuvant to Adriamycin therapy.
- Combining MF with ADR significantly enhances the inhibition of osteosarcoma cell proliferation compared to individual treatments.
- This approach holds promise for reducing chemotherapy drug dosage and associated morbidity.
More Related Videos
10:03Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
Published on: November 21, 2019
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023